Coal India Limited
Coal India Limited has informed the Exchange about General Updates-In-principle approval of Listing of South Eastern Coalfields Limited (SECL), a Wholly owned subsidiary of Coal India Limited. |SUBJECT: General Updates Source link
Coal India Limited has informed the Exchange about General Updates-In-principle approval of Listing of South Eastern Coalfields Limited (SECL), a Wholly owned subsidiary of Coal India Limited. |SUBJECT: General Updates Source link
Educomp Solutions Limited has informed the Exchange regarding Appointment of M/s GDR & Associates LLP, chartered Accountants. as Other of the company w.e.f. December 23, 2025. |SUBJECT: Appointment Source link
MAHINDRA & MAHINDRA FINANCIAL SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 28-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . |SUBJECT: Board Meeting Intimation Source link
Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on December 23, 2025. |SUBJECT: Outcome of Board Meeting Source link
SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED has informed the Exchange regarding Acquisition |SUBJECT: Acquisition-XBRL Source link
Krishana Phoschem Limited has informed the Exchange about Action(s) initiated or orders passed |SUBJECT: Action(s) initiated or orders passed Source link
DABUR INDIA LIMITED has informed the Exchange about Board Meeting to be held on 29-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . |SUBJECT: Board Meeting Intimation Source link
BAJAJ CONSUMER CARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |SUBJECT: Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent Source link
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled “Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP,30 mg/30 mL (1 mg/mL) Multiple-Dose Vial”. |SUBJECT: Press Release Source link